CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 8,662,091	$ 4,164,323
Prepaid expenses and other current assets	1,119,321	1,213,984
Total current assets	9,781,412	5,378,307
Operating lease right-of-use assets	196,249	268,571
Assets, Total	9,977,661	5,646,878
Current liabilities:
Accounts payable	2,027,509	1,284,612
Accrued expenses and other current liabilities	1,560,430	762,835
Related party payable	143,080	142,459
Operating lease liability, current	141,070	116,323
Debentures	6,785,812	0
Total current liabilities	10,657,901	2,306,229
Loan payable	29,462	0
Operating lease liability, non-current	95,188	205,945
Total liabilities	10,782,551	2,512,174
Commitments and contingencies
Shareholders' (deficit) equity
Common shares, no par value; unlimited shares authorized; 20,971,122 and 11,816,721 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	4	30,518,195
Common shares to be issued	313,934	0
Additional paid-in capital	6,449,863	1,520,412
Accumulated other comprehensive income	10,676	0
Accumulated deficit	(5)	(28,903,903)
Total shareholders' equity attributable to Medicus Pharma Ltd.	(910,126)	3,134,704
Non-controlling interests	105,236	0
Total shareholders' (deficit) equity	(804,890)	3,134,704
Total liabilities and shareholders' (deficit) equity	$ 9,977,661	$ 5,646,878